Personalizing Prostate Cancer Care With Genetic Testing, PARP Inhibitors
Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining treatment with PARP inhibitors.
Related Articles
Interview: New ICN president hopes to empower profession | Nursing Times
Read an exclusive interview with Dr José Luis Cobos Serrano, the new president of the International Council of Nurses.
Acting director of professional practice named amid NMC reshuffle | Nursing Times
Find out who has been appointed as the Nursing and Midwifery Council’s acting director of professional practice, amid an executive reshuffle.
Nurses spotlight bladder and bowel care gaps | Nursing Times
Read about the key topics that were discussed at a 2025 meeting of the All-Party Parliamentary Group for Bladder and Bowel Continence Care.
Nurses spotlight bladder and bowel care gaps | Nursing Times
Read about the key topics that were discussed at a 2025 meeting of the All-Party Parliamentary Group for Bladder and Bowel Continence Care.
‘I left Westminster Abbey with a great deal of pride in being a nurse’ | Nursing Times
Student editor Sana Gul on her experience of attending the 60th Florence Nightingale Foundation Commemorative Service at Westminster Abbey.
Nursing Times Workforce Summit & Awards 2025
The Nursing Times Workforce Summit & Awards is a collaborative effort with the sector, bringing together expertise in workforce planning and real-world case studies. Its…
Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
FDA Approves Perioperative Keytruda for Locally Advanced Head and Neck Cancer
Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free survival versus standard care.
Columvi Combo Enhances Survival Outcomes in R/R Lymphoma Subgroup
Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma.
Beyond Treatment: How Support Groups Helped Me Embrace My New Normal
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.